HEADER HYDROLASE 20-MAY-08 3D6S OBSLTE 27-APR-22 3D6S 5VPK TITLE CRYSTAL STRUCTURE OF MITE ALLERGEN DER F 1 CAVEAT 3D6S NAG A 224 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALLERGEN DER F I; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 99-321; COMPND 5 SYNONYM: MAJOR MITE FECAL ALLERGEN DER F 1, PEPTIDASE 1; COMPND 6 EC: 3.4.22.65 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DERMATOPHAGOIDES FARINAE; SOURCE 3 ORGANISM_COMMON: HOUSE-DUST MITE; SOURCE 4 ORGANISM_TAXID: 6954 KEYWDS ALLERGY, DUST MITES, ALLERGEN, GLYCOPROTEIN, HYDROLASE, PROTEASE, KEYWDS 2 SECRETED, THIOL PROTEASE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR M.CHRUSZCZ,M.D.CHAPMAN,L.D.VAILES,A.POMES,W.MINOR REVDAT 7 27-APR-22 3D6S 1 OBSLTE REVDAT 6 13-APR-22 3D6S 1 AUTHOR JRNL HETSYN REVDAT 5 29-JUL-20 3D6S 1 CAVEAT COMPND REMARK HET REVDAT 5 2 1 HETNAM FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 24-JUL-19 3D6S 1 REMARK LINK REVDAT 3 13-JUL-11 3D6S 1 VERSN REVDAT 2 03-MAR-09 3D6S 1 JRNL REVDAT 1 10-FEB-09 3D6S 0 JRNL AUTH M.CHRUSZCZ,M.D.CHAPMAN,L.D.VAILES,E.A.STURA,J.M.SAINT-REMY, JRNL AUTH 2 W.MINOR,A.POMES JRNL TITL CRYSTAL STRUCTURES OF MITE ALLERGENS DER F 1 AND DER P 1 JRNL TITL 2 REVEAL DIFFERENCES IN SURFACE-EXPOSED RESIDUES THAT MAY JRNL TITL 3 INFLUENCE ANTIBODY BINDING JRNL REF J.MOL.BIOL. V. 386 520 2009 JRNL REFN ISSN 0022-2836 JRNL PMID 19136006 JRNL DOI 10.1016/J.JMB.2008.12.049 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.211 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.208 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1979 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 37185 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.199 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1676 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 31562 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5233 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 311 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 ANGLE DISTANCES (A) : 0.035 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.077 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.112 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.404 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.024 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3D6S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047663. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 10.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9794 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : 27.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : 0.51400 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000, MOLREP, PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2AS8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 0.5M L-ARGININE, REMARK 280 0.05M NACL, PH 7.5. CRYSTALLIZATION SOLUTION: 2M NH4 SULFATE, REMARK 280 0.12M LI SULFATE, 0.004M EDTA, 0.1M CAPS, PH 10.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K, PH 10.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.87300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.43650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 58.30950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA C 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR B 1 O REMARK 470 CYS B 4 O REMARK 470 GLN B 182 CB CG CD OE1 NE2 REMARK 470 ARG C 5 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 7 CG OD1 ND2 REMARK 470 VAL C 9 CG1 CG2 REMARK 470 ASN C 10 CG OD1 ND2 REMARK 470 GLU C 14 CG CD OE1 OE2 REMARK 470 GLN C 69 CG CD OE1 NE2 REMARK 470 ARG C 100 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 103 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 105 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 106 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 108 CG OD1 ND2 REMARK 470 LYS C 126 CG CD CE NZ REMARK 470 ARG C 149 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 157 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 182 CG CD OE1 NE2 REMARK 470 MET C 223 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN B 53 O5 NAG B 224 1.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 70 44.56 -162.06 REMARK 500 TYR A 95 78.23 -154.32 REMARK 500 ASP A 194 177.15 64.85 REMARK 500 ASN A 210 40.18 37.96 REMARK 500 HIS B 70 53.72 -158.28 REMARK 500 ASN B 116 179.70 178.46 REMARK 500 TYR B 166 -80.01 -89.72 REMARK 500 GLN B 182 73.07 43.90 REMARK 500 ASP B 184 105.55 -162.38 REMARK 500 ASP B 194 175.81 79.43 REMARK 500 MET B 213 21.92 48.86 REMARK 500 LEU C 15 117.81 -168.68 REMARK 500 ASP C 65 -60.74 -100.16 REMARK 500 ASN C 116 -168.10 -161.71 REMARK 500 TYR C 166 -67.73 -104.89 REMARK 500 SER C 192 42.23 -104.02 REMARK 500 ASP C 194 172.83 68.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS B 32 GLY B 33 147.96 REMARK 500 REMARK 500 REMARK: NULL DBREF 3D6S A 1 223 UNP P16311 PEPT1_DERFA 99 321 DBREF 3D6S B 1 223 UNP P16311 PEPT1_DERFA 99 321 DBREF 3D6S C 1 223 UNP P16311 PEPT1_DERFA 99 321 SEQRES 1 A 223 THR SER ALA CYS ARG ILE ASN SER VAL ASN VAL PRO SER SEQRES 2 A 223 GLU LEU ASP LEU ARG SER LEU ARG THR VAL THR PRO ILE SEQRES 3 A 223 ARG MET GLN GLY GLY CYS GLY SER CYS TRP ALA PHE SER SEQRES 4 A 223 GLY VAL ALA ALA THR GLU SER ALA TYR LEU ALA TYR ARG SEQRES 5 A 223 ASN THR SER LEU ASP LEU SER GLU GLN GLU LEU VAL ASP SEQRES 6 A 223 CYS ALA SER GLN HIS GLY CYS HIS GLY ASP THR ILE PRO SEQRES 7 A 223 ARG GLY ILE GLU TYR ILE GLN GLN ASN GLY VAL VAL GLU SEQRES 8 A 223 GLU ARG SER TYR PRO TYR VAL ALA ARG GLU GLN ARG CYS SEQRES 9 A 223 ARG ARG PRO ASN SER GLN HIS TYR GLY ILE SER ASN TYR SEQRES 10 A 223 CYS GLN ILE TYR PRO PRO ASP VAL LYS GLN ILE ARG GLU SEQRES 11 A 223 ALA LEU THR GLN THR HIS THR ALA ILE ALA VAL ILE ILE SEQRES 12 A 223 GLY ILE LYS ASP LEU ARG ALA PHE GLN HIS TYR ASP GLY SEQRES 13 A 223 ARG THR ILE ILE GLN HIS ASP ASN GLY TYR GLN PRO ASN SEQRES 14 A 223 TYR HIS ALA VAL ASN ILE VAL GLY TYR GLY SER THR GLN SEQRES 15 A 223 GLY ASP ASP TYR TRP ILE VAL ARG ASN SER TRP ASP THR SEQRES 16 A 223 THR TRP GLY ASP SER GLY TYR GLY TYR PHE GLN ALA GLY SEQRES 17 A 223 ASN ASN LEU MET MET ILE GLU GLN TYR PRO TYR VAL VAL SEQRES 18 A 223 ILE MET SEQRES 1 B 223 THR SER ALA CYS ARG ILE ASN SER VAL ASN VAL PRO SER SEQRES 2 B 223 GLU LEU ASP LEU ARG SER LEU ARG THR VAL THR PRO ILE SEQRES 3 B 223 ARG MET GLN GLY GLY CYS GLY SER CYS TRP ALA PHE SER SEQRES 4 B 223 GLY VAL ALA ALA THR GLU SER ALA TYR LEU ALA TYR ARG SEQRES 5 B 223 ASN THR SER LEU ASP LEU SER GLU GLN GLU LEU VAL ASP SEQRES 6 B 223 CYS ALA SER GLN HIS GLY CYS HIS GLY ASP THR ILE PRO SEQRES 7 B 223 ARG GLY ILE GLU TYR ILE GLN GLN ASN GLY VAL VAL GLU SEQRES 8 B 223 GLU ARG SER TYR PRO TYR VAL ALA ARG GLU GLN ARG CYS SEQRES 9 B 223 ARG ARG PRO ASN SER GLN HIS TYR GLY ILE SER ASN TYR SEQRES 10 B 223 CYS GLN ILE TYR PRO PRO ASP VAL LYS GLN ILE ARG GLU SEQRES 11 B 223 ALA LEU THR GLN THR HIS THR ALA ILE ALA VAL ILE ILE SEQRES 12 B 223 GLY ILE LYS ASP LEU ARG ALA PHE GLN HIS TYR ASP GLY SEQRES 13 B 223 ARG THR ILE ILE GLN HIS ASP ASN GLY TYR GLN PRO ASN SEQRES 14 B 223 TYR HIS ALA VAL ASN ILE VAL GLY TYR GLY SER THR GLN SEQRES 15 B 223 GLY ASP ASP TYR TRP ILE VAL ARG ASN SER TRP ASP THR SEQRES 16 B 223 THR TRP GLY ASP SER GLY TYR GLY TYR PHE GLN ALA GLY SEQRES 17 B 223 ASN ASN LEU MET MET ILE GLU GLN TYR PRO TYR VAL VAL SEQRES 18 B 223 ILE MET SEQRES 1 C 223 THR SER ALA CYS ARG ILE ASN SER VAL ASN VAL PRO SER SEQRES 2 C 223 GLU LEU ASP LEU ARG SER LEU ARG THR VAL THR PRO ILE SEQRES 3 C 223 ARG MET GLN GLY GLY CYS GLY SER CYS TRP ALA PHE SER SEQRES 4 C 223 GLY VAL ALA ALA THR GLU SER ALA TYR LEU ALA TYR ARG SEQRES 5 C 223 ASN THR SER LEU ASP LEU SER GLU GLN GLU LEU VAL ASP SEQRES 6 C 223 CYS ALA SER GLN HIS GLY CYS HIS GLY ASP THR ILE PRO SEQRES 7 C 223 ARG GLY ILE GLU TYR ILE GLN GLN ASN GLY VAL VAL GLU SEQRES 8 C 223 GLU ARG SER TYR PRO TYR VAL ALA ARG GLU GLN ARG CYS SEQRES 9 C 223 ARG ARG PRO ASN SER GLN HIS TYR GLY ILE SER ASN TYR SEQRES 10 C 223 CYS GLN ILE TYR PRO PRO ASP VAL LYS GLN ILE ARG GLU SEQRES 11 C 223 ALA LEU THR GLN THR HIS THR ALA ILE ALA VAL ILE ILE SEQRES 12 C 223 GLY ILE LYS ASP LEU ARG ALA PHE GLN HIS TYR ASP GLY SEQRES 13 C 223 ARG THR ILE ILE GLN HIS ASP ASN GLY TYR GLN PRO ASN SEQRES 14 C 223 TYR HIS ALA VAL ASN ILE VAL GLY TYR GLY SER THR GLN SEQRES 15 C 223 GLY ASP ASP TYR TRP ILE VAL ARG ASN SER TRP ASP THR SEQRES 16 C 223 THR TRP GLY ASP SER GLY TYR GLY TYR PHE GLN ALA GLY SEQRES 17 C 223 ASN ASN LEU MET MET ILE GLU GLN TYR PRO TYR VAL VAL SEQRES 18 C 223 ILE MET MODRES 3D6S ASN B 53 ASN GLYCOSYLATION SITE MODRES 3D6S ASN A 53 ASN GLYCOSYLATION SITE HET NAG A 224 14 HET SO4 A 225 5 HET SO4 A 226 5 HET SO4 A 227 5 HET NAG B 224 14 HET SO4 B 225 5 HET SO4 B 226 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 5 SO4 5(O4 S 2-) FORMUL 11 HOH *311(H2 O) HELIX 1 1 LEU A 17 ARG A 21 1 5 HELIX 2 2 SER A 34 ASN A 53 1 20 HELIX 3 3 SER A 59 ALA A 67 1 9 HELIX 4 4 THR A 76 GLY A 88 1 13 HELIX 5 5 GLU A 91 TYR A 95 5 5 HELIX 6 6 ASP A 124 HIS A 136 1 13 HELIX 7 7 ASP A 147 HIS A 153 1 7 HELIX 8 8 ASN A 210 ILE A 214 5 5 HELIX 9 9 SER B 34 ASN B 53 1 20 HELIX 10 10 SER B 59 ALA B 67 1 9 HELIX 11 11 HIS B 70 GLY B 74 5 5 HELIX 12 12 THR B 76 GLY B 88 1 13 HELIX 13 13 ASP B 124 HIS B 136 1 13 HELIX 14 14 ASP B 147 HIS B 153 1 7 HELIX 15 15 ASN B 210 ILE B 214 5 5 HELIX 16 16 SER C 34 ARG C 52 1 19 HELIX 17 17 SER C 59 ALA C 67 1 9 HELIX 18 18 THR C 76 GLY C 88 1 13 HELIX 19 19 ASP C 124 HIS C 136 1 13 HELIX 20 20 ASP C 147 HIS C 153 1 7 HELIX 21 21 ASN C 210 ILE C 214 5 5 SHEET 1 A 3 LEU A 15 ASP A 16 0 SHEET 2 A 3 ASN A 169 SER A 180 -1 O TYR A 178 N LEU A 15 SHEET 3 A 3 ILE A 139 ILE A 145 -1 N ILE A 143 O HIS A 171 SHEET 1 B 4 LEU A 15 ASP A 16 0 SHEET 2 B 4 ASN A 169 SER A 180 -1 O TYR A 178 N LEU A 15 SHEET 3 B 4 ASP A 185 ARG A 190 -1 O TYR A 186 N GLY A 179 SHEET 4 B 4 TYR A 202 GLN A 206 -1 O PHE A 205 N TRP A 187 SHEET 1 C 2 ASN A 116 GLN A 119 0 SHEET 2 C 2 TYR A 219 ILE A 222 -1 O VAL A 220 N CYS A 118 SHEET 1 D 5 LEU B 15 ASP B 16 0 SHEET 2 D 5 ASN B 169 SER B 180 -1 O TYR B 178 N LEU B 15 SHEET 3 D 5 ILE B 139 ILE B 145 -1 N ILE B 143 O HIS B 171 SHEET 4 D 5 PRO B 218 ILE B 222 -1 O TYR B 219 N ALA B 140 SHEET 5 D 5 ASN B 116 GLN B 119 -1 N CYS B 118 O VAL B 220 SHEET 1 E 5 LEU B 15 ASP B 16 0 SHEET 2 E 5 ASN B 169 SER B 180 -1 O TYR B 178 N LEU B 15 SHEET 3 E 5 ASP B 185 ARG B 190 -1 O ILE B 188 N VAL B 176 SHEET 4 E 5 TYR B 202 GLN B 206 -1 O PHE B 205 N TRP B 187 SHEET 5 E 5 ILE B 159 ILE B 160 1 N ILE B 160 O TYR B 204 SHEET 1 F 3 LEU C 15 ASP C 16 0 SHEET 2 F 3 ASN C 169 THR C 181 -1 O TYR C 178 N LEU C 15 SHEET 3 F 3 ILE C 139 ILE C 145 -1 N ILE C 139 O ILE C 175 SHEET 1 G 4 LEU C 15 ASP C 16 0 SHEET 2 G 4 ASN C 169 THR C 181 -1 O TYR C 178 N LEU C 15 SHEET 3 G 4 ASP C 184 ARG C 190 -1 O ARG C 190 N ASN C 174 SHEET 4 G 4 TYR C 202 GLN C 206 -1 O GLY C 203 N VAL C 189 SHEET 1 H 2 VAL C 89 VAL C 90 0 SHEET 2 H 2 HIS C 111 TYR C 112 -1 O TYR C 112 N VAL C 89 SHEET 1 I 2 ASN C 116 GLN C 119 0 SHEET 2 I 2 TYR C 219 ILE C 222 -1 O ILE C 222 N ASN C 116 SSBOND 1 CYS A 4 CYS A 118 1555 1555 2.06 SSBOND 2 CYS A 32 CYS A 72 1555 1555 2.01 SSBOND 3 CYS A 66 CYS A 104 1555 1555 2.05 SSBOND 4 CYS B 4 CYS B 118 1555 1555 2.00 SSBOND 5 CYS B 32 CYS B 72 1555 1555 2.19 SSBOND 6 CYS B 66 CYS B 104 1555 1555 2.05 SSBOND 7 CYS C 4 CYS C 118 1555 1555 2.03 SSBOND 8 CYS C 32 CYS C 72 1555 1555 2.04 SSBOND 9 CYS C 66 CYS C 104 1555 1555 2.05 LINK ND2 ASN A 53 C1 NAG A 224 1555 1555 1.37 LINK ND2 ASN B 53 C1 NAG B 224 1555 1555 1.45 CISPEP 1 TYR A 121 PRO A 122 0 -9.30 CISPEP 2 TYR B 121 PRO B 122 0 -1.49 CISPEP 3 TYR C 121 PRO C 122 0 -7.38 CRYST1 91.159 91.159 77.746 90.00 90.00 90.00 P 41 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010970 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010970 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012862 0.00000